Customized load-bearing and bioactive functionally-graded implant for treatment of osteonecrosis

Patent metadata

Field	Value
Publication number	US-11666445-B2
Application number	US-202016904408-A
Country	US
Kind code	B2
Filing date	Jun 17, 2020
Priority date	Mar 20, 2015
Publication date	Jun 6, 2023
Grant date	Jun 6, 2023

Abstract

An engineered medical device for treatment of osteonecrosis is provided where the size, porosity and ceramic content of the device can be personalized based on an individual patient's anatomical and physiological condition. The device distinguishes different segments mimicking anatomically-relevant cortical and cancellous segments, in which the cortical segments of the device can sustain mechanical loading, and the cancellous segment of the device can promote bone ingrowth, osteogenesis and angiogenesis.

First claim

The invention claimed is:

1. An engineered medical osteonecrosis treatment device, comprising:
a cylindrically-shaped biodegradable scaffold having a central channel in a cylindrical alignment, wherein the central channel is sufficiently wide in diameter to contain cargo, wherein the cylindrically-shaped biodegradable scaffold is made of filaments having three cylindrical sections of spatially graded chemical composition, porosity and mechanical strength,
wherein the three cylindrical sections distinguish in the cylindrical alignment with each other a proximal cylindrical section, a distal cylindrical section and a single intermediary cylindrical section positioned in between the proximal and distal cylindrical sections,
wherein the intermediary cylindrical section is longer than each of the proximal and distal cylindrical sections,
wherein a porosity of the proximal and distal cylindrical sections across the entire proximal and distal cylindrical sections is less than a porosity across the entire intermediary cylindrical section, and wherein the proximal cylindrical section has a porosity which is less than the porosity of the distal cylindrical section, and wherein a mechanical strength across the entire proximal and distal cylindrical sections is higher than a mechanical strength across the entire intermediary cylindrical section.

2. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the cargo is one or more drugs, one or more growth factors, one or more cell, one or more biomolecules, or a combination thereof.

3. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the proximal cylindrical section has a mechanical strength which is less than the mechanical strength of the distal cylindrical section.

4. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the scaffold is a made of a polymer and a ceramic.

5. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the scaffold is made of polycaprolactone (PCL), calcium phosphate, beta-tricalcium phosphate (beta-TCP), hydroxyapatite, or a combination thereof.

6. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the three cylindrical sections comprise calcium phosphate or beta-tricalcium phosphate and wherein the proximal and distal cylindrical sections have a higher calcium phosphate or beta-tricalcium phosphate concentration than the intermediary cylindrical section resulting in (i) the mechanical strength difference, (ii) an osteoconductivity difference, (iii) a degradation difference between proximal and distal cylindrical sections compared to the intermediary cylindrical section, or a combination thereof.

7. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the mechanical strength difference results from the difference in the porosity between proximal and distal cylindrical sections compared to the intermediary cylindrical section.

8. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the mechanical strength for the cylindrical sections varies in a range of 0.5 to 6 MPa, wherein a stiffness for the cylindrical sections varies in a range of 20 to 100 Mpa, while preserving that the mechanical strength of the proximal and distal cylindrical sections is higher than the mechanical strength of the intermediary cylindrical section.

9. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the porosity difference changes gradually from the proximal cylindrical section to the intermediary cylindrical section and to the distal cylindrical section, while preserving that the porosity of the proximal and distal cylindrical sections is less than the porosity of the intermediary cylindrical section.

10. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the mechanical strength difference changes gradually from the proximal cylindrical section to the intermediary cylindrical section and to the distal cylindrical section, while preserving that the mechanical strength of the proximal and distal cylindrical sections is higher than the mechanical strength of the intermediary cylindrical section.

11. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the porosity of the proximal and distal cylindrical section is defined between 0% to 40% and wherein the porosity of the intermediary cylindrical section is defined above 40% to 95%.

12. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the porosity of the proximal and distal cylindrical section is defined between 0% to 30% and wherein the porosity of the intermediary cylindrical section is defined above 30% to 95%.

13. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the scaffold has a biodegradation rate that matches bone regeneration, wherein the biodegradation rate can be tailored specifically to a patient's needs.

14. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the three cylindrical sections each have a biodegradation rate that matches bone regeneration intended and designed for its respective cylindrical sections.

15. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the medical device is adapted to fit in a tunnel bored in a femoral head intended for reconstruction of an osteonecrotic area.

16. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the proximal and distal cylindrical sections mimic cortical bone.

17. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the proximal cylindrical section mimics a subchondral surface profile.

18. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the intermediary cylindrical section is intended to replace trabecular bone of necrotic tissue.

19. The engineered medical osteonecrosis treatment device as set forth in claim 1 , wherein the intermediary cylindrical section is a template for vascularization and bone ingrowth.

Assignees

• Univ Leland Stanford Junior

Inventors

• Yang Yunzhi
• Goodman Stuart B
• Shanjani Yaser
• Pan Chi-Chun

Classifications

• A61F2002/30011

  differing in porosity · CPC title

• A61F2002/30062

  (bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive · CPC title

• A61F2002/3093

  for promoting ingrowth of bone tissue · CPC title

• A61F2310/00796

  Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite · CPC title

• A61F2002/30224

  cylindrical · CPC title